Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.

about

Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.

Item

http://www.wikidata.org/entity/Q48232899

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Hypophosphatemia is Associated ...... ium to Patients for Brain MRI.

@en

Hypophosphatemia is Associated ...... ium to Patients for Brain MRI.

@nl

type

Item

label

Hypophosphatemia is Associated ...... ium to Patients for Brain MRI.

@en

Hypophosphatemia is Associated ...... ium to Patients for Brain MRI.

@nl

prefLabel

Hypophosphatemia is Associated ...... ium to Patients for Brain MRI.

@en

Hypophosphatemia is Associated ...... ium to Patients for Brain MRI.

@nl

P1476

Hypophosphatemia is Associated ...... nium to Patients for Brain MRI

@en

P2093

Diego Cadavid

http://www.w3.org/2001/XMLSchema#string

Jojy Cheriyan

http://www.w3.org/2001/XMLSchema#string

Leo J Wolansky

http://www.w3.org/2001/XMLSchema#string

Mershad Haghighi

http://www.w3.org/2001/XMLSchema#string

Soyeon Kim

http://www.w3.org/2001/XMLSchema#string

Stuart D Cook

http://www.w3.org/2001/XMLSchema#string

P2860

Tolerance data of Gd-DTPA: a review.

Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy.

Nephrogenic fibrosing dermopathy in pediatric patients.

Tissue deposition of gadolinium and development of NSF: a convergence of factors.

Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.

Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.

Triple-dose versus single-dose gadoteridol in multiple sclerosis patients.

Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials.

Gadoteridol in multiple sclerosis patients. A comparison of single and triple dose with immediate vs. delayed imaging.

Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.

P304

379-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JON.12241

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vineet Punia

P577

2015-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25867798

http://www.w3.org/2001/XMLSchema#string